Bergeson & Campbell, P.C. (B&C®) and its global consulting affiliate The Acta Group (Acta®) and consortia management affiliate B&C® Consortia Management, L.L.C. (BCCM) are pleased to offer you our Forecast 2023, our seasoned team’s collective take on what to expect regarding global industrial, agricultural, and biocidal chemical initiatives in the New Year. We have worked hard to offer our best-informed judgment on the trends and key developments we expect to see in 2023. Here at home, most would agree the Biden Administration has made bold and consequential ... read more >

The Acta Group (Acta®) affiliate Bergeson & Campbell, P.C.’s (B&C®) October 26, 2022, webinar “Food Safety Issues in the United States” is now available for on-demand viewing at https://attendee.gotowebinar.com/recording/8196944274166221318.   During this one-hour webinar, Thomas J. Dunn, Managing Director, Flexpacknology LLC; Karin F. Baron, Senior Regulatory Consultant, Acta; and Lynn L. Bergeson, President, Acta, review the seven major rules of the Food Safety Modernization Act (FSMA), discuss food safety over the past decade, and ... read more >

Bergeson & Campbell, P.C. (B&C®) and its consulting affiliate The Acta Group (Acta®) and consortia management affiliate B&C® Consortia Management, L.L.C. (BCCM) are pleased to offer you our Forecast 2022. The extraordinary diversity and complexity of global industrial, agricultural, and biocidal chemical initiatives in which our clients engage are reflected in the detailed summary that follows, prepared by the legal, scientific, and regulatory professionals of B&C, Acta, and BCCM. In this comprehensive overview, we offer our best informed judgment as to the trends ... read more >

On July 28, 2021, Lynn L. Bergeson, President, The Acta Group (Acta®), was quoted by Chemical Watch regarding a U.S. Food and Drug Administration (FDA) plan to evaluate fluorinated plastic food containers for potential per- and polyfluoroalkyl substance (PFAS) contamination.  The FDA said that while companies must fulfil "strict data requirements" to demonstrate non-hazardous conditions of use before approval, it reassesses risks as knowledge advances, such as by looking at the research from domestic and international agencies. "The FDA may revoke ... read more >

Available On Demand Overview: Cosmetic formulations often contain preservatives to protect the product’s integrity and extend its shelf life.  The regulatory requirements that product manufacturers must adhere to when incorporating preservatives into their products and what claims are permissible on their product labels is far from harmonized globally, and the path is not getting easier.  This webinar will provide an overview of cosmetic ingredient regulations in the U.S., the European Union (EU), Canada, and China, focusing on how preservatives are regulated in cosmetic ... read more >

Preserving Cosmetics on a Global Scale: It is Harder than You Think Wednesday, May 22, 2019 1:00 p.m. - 2:00 p.m. (EDT) Register Today Overview: Cosmetic formulations often contain preservatives to protect the product’s integrity and extend its shelf life. The regulatory requirements that product manufacturers must adhere to when incorporating preservatives into their products and what claims are permissible on their product labels is far from harmonized globally, and the path is not getting easier. This webinar will provide an overview of cosmetic ingredient regulations in the ... read more >

On October 17, 2018, The Acta Group (Acta®) affiliate Bergeson & Campbell, P.C. (B&C®) presented a complimentary webinar regarding pending implementation dates of key U.S. Food and Drug Administration (FDA) Food Safety Modernization Act (FSMA) rules. “Keeping up with FSMA – Rules, Obligations, and Key Compliance Dates” was presented by Karin F. Baron, MSPH, Senior Regulatory Consultant, B&C, Lynn L. Bergeson, Managing Partner, B&C, and Scott J. Burya, Ph.D., Regulatory Chemist, B&C, and showed registrants how to prepare for forthcoming deadlines ... read more >

  Wednesday, October 17, 2018 1:00 p.m. - 2:00 p.m. (EDT)  Complimentary Registration Available Online   Speakers: ■  Karin F. Baron, MSPH Senior Regulatory Consultant, Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®)   ■  Lynn L. Bergeson Managing Partner, B&C; President, Acta   ■  Scott J. Burya, Ph.D. Regulatory Chemist, B&C and Acta   With key implementation dates of several core elements of the U.S. Food and Drug ... read more >

On December 18, 2017, Lynn L. Bergeson, President of The Acta Group (Acta®), was quoted by the Bloomberg BNA Daily Environment Report in the article “FDA Pushes Risk-Based Approach to Nanomaterial Drugs.” Developers of drugs containing nanomaterials—substances so small they can't be seen with a regular microscope—got some advice on how to assess their risks in FDA draft guidance issued Dec. 15. […] Without having read it in detail yet, Lynn Bergeson, managing partner of Bergeson & Campbell PC, told Bloomberg BNA in a Nov. 15 email the FDA ... read more >

On October 6, 2017, Inside EPA quoted a recent memorandum from The Acta Group (Acta®) in the article “EPA wins power to oversee biotech mosquito controls.” EPA and the Food and Drug Administration (FDA) have issued new guidance clarifying that EPA has authority for regulating biotechnology (Bt) products such as genetically modified mosquitoes that are used to control the pests, a step that one industry law firm says will be helpful for navigating a federal “jurisdictional quagmire." […] In an Oct. 5 blog, the law firm Bergeson and Campbell PC, ... read more >